CLINICAL_TRIALS
trial_result
· 2009-04-02
Clinical Trial Update: A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease [Phase 2]
Summary
Phase 2 study evaluating Fabrazyme for Fabry disease assessed safety and efficacy; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Fabry Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-04-02